CD Genomics Optimized Inherited Disease Panels for Genetic Diseases Research

SHIRLEY, NY – Nov 6, 2020 - Based on rich experience in targeted sequencing, CD Genomics has developed a specialized platform for targeted sequencing of disease-related genes to accelerate research on disease pathogenesis, disease identification, biomarker discovery, targeted drug development, etc. These days, the product manager of CD Genomics announced that the company has recently optimized inherited disease panels, which can help researchers detect genetic mutations more efficiently and accurately associated with a variety of genetic diseases.
 
CD Genomics offers predesigend NGS panels, which include a designed library of targeted sequencing, as well as a custom panel that allows customers to select genes of interest to design their own sequencing panels. The targeted sequencing technology with targeted enrichment strategies can provide you with genetic disease screening. These services are pre-designed groups that help researchers more efficiently and accurately detect genetic mutations associated with a variety of genetic diseases.
 
“CD Genomics provides accurate and cost-effective inherited disease panels sequencing and bioinformatics analysis. Our professional expert team executes quality management, following every procedure to ensure confident and unbiased results.” commented vice president of CD Genomics.
 
CD Genomics offers five related services for research use:
 
Mitochondrial Diseases Panel Sequencing
In recent years, there has been a steady rise in cases related to mitochondria. Mitochondrial dysfunction has been found in many diseases, such as cancer, blindness, deafness, kidney disease, and even related to aging and neurotrophic diseases, such as Parkinson’s disease and Alzheimer’s disease. CD Genomics provides a predesigned panel enriches for and provides complete coverage of all 37 genes of the ~17 kb mitochondrial genome which can detect even low abundance variations accurately and efficiently to accelerate your experimental progress.
 
Medical Exome Panel
CD Genomics' medical exome panel includes 3800 genes associated with different categories of human genetic diseases. The genes are sequenced using NGS technology to detect the mutations that cause inherited diseases.
 
Whole Exome Sequencing
CD Genomics provides a full whole exome sequencing service package including sample standardization, exome capture, library construction, deep sequencing, raw data quality control, and bioinformatics analysis.
 
Ophthalmic Panel Sequencing
Ophthalmic research panel is a predesigned panel for detecting mutations in genes associated with eye diseases.
 
Inherited Heart Disease Panel Sequencing
To support clinical research, CD Genomics provides a predesigned inherited heart disease panel utilizing hybrid capture sequencing technology by Illumina system. This panel offers 102 genes associated with heart disease. And also, you can choose the genes from the gene list to customize your exclusive panel.
 
“As a company that specializes in providing genome services and products, CD Genomics has been committed to offering different kinds of inherited disease panels for inherited disease researches. Targeted NGS sequencing facilitates the sequencing of a large number of genes and samples in a single and cost-effective assay,” said Dr. Charlie.
 
About CD Genomics
Based on extensive experience in sequencing, microarray analysis, library construction and genotyping, CD Genomics is further developed with the mission to accelerate the entire genetic industry toward breakthrough discoveries.